Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01626989 · ClinicalTrials.gov registry record · NA
Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders
A NA study, sponsored by Philips Respironics.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT01626989 is a NA study that has completed, run by Philips Respironics. The registered enrollment target is 44 participants.
The verdict
NCT01626989, a NA study, has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
Comparing two BiPAP autoSV devices in participants with complex sleep apnea and determining if the new device will treat those participants no worse than when compared to its predecessor device.
Interventions
- DEVICE BiPAP auto Advanced
- DEVICE BiPAP auto SV4
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01626989
The ClinicalTrials.gov registry entry for NCT01626989 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BiPAP auto Advanced is the first listed.
NCT01626989 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01626989 about?
NCT01626989 is a clinical study titled "Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders". Comparing two BiPAP autoSV devices in participants with complex sleep apnea and determining if the new device will treat those participants no worse than when compared to its predecessor device.
What is the current status of trial NCT01626989?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2010-06. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01626989?
The interventions under investigation include: BiPAP auto Advanced (DEVICE), BiPAP auto SV4 (DEVICE).
Who is sponsoring clinical trial NCT01626989?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.